Cargando…
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
INTRODUCTION: Despite the availability of new antibiotics such as daptomycin, methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia continues to be associated with high clinical failure rates. Combination therapy has been proposed as an alternative to improve outcomes but there is a lack of...
Autores principales: | Shaw, E, Miró, J M, Puig-Asensio, M, Pigrau, C, Barcenilla, F, Murillas, J, Garcia-Pardo, G, Espejo, E, Padilla, B, Garcia-Reyne, A, Pasquau, J, Rodriguez-Baño, J, López-Contreras, J, Montero, M, de la Calle, C, Pintado, V, Calbo, E, Gasch, O, Montejo, M, Salavert, M, Garcia-Pais, M J, Carratalà, J, Pujol, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360784/ https://www.ncbi.nlm.nih.gov/pubmed/25762232 http://dx.doi.org/10.1136/bmjopen-2014-006723 |
Ejemplares similares
-
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
por: Pujol, Miquel, et al.
Publicado: (2020) -
LB3. Daptomycin Plus Fosfomycin vs. Daptomycin Monotherapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Multicenter, Randomized, Clinical Trial
por: Pujol, Miquel, et al.
Publicado: (2018) -
High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
por: Chen, Liang-Yu, et al.
Publicado: (2011) -
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012) -
Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains
por: Scull, Erin M., et al.
Publicado: (2020)